UNITED
STATES


SECURITIES
AND EXCHANGE COMMISSION


Washington,
D. C. 20549





FORM
10-Q


(Mark
One)


x
            QUARTERLY
      REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
      1934





For the
quarterly period ended March 31, 2009





o
            TRANSITION
      REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
      1934





For the
transition period from ____________  to____________




Commission
file number 000-51140





CuraTech Industries,
Inc.


(Exact
name of registrant as specified in its charter)





NEVADA
            
            87-0649332(State
      or other jurisdiction of
            
            (I.R.S.
      Employer identification No.)incorporation
      or organization)





6337
      Highland Drive, No. 1053Salt Lake City, Utah
  84121(Address
      of principal executive offices) (Zip
Code)





Registrant’s
telephone number: (801) 616-2355





Indicate
by check mark whether the registrant (1) has filed all reports required to be
filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the registrant was required
to file such reports), and (2) has been subject to such filing requirements for
the past 90 days.  Yes x No o





Indicate
by check mark whether the registrant has submitted electronically and posted on
its corporate Web site, if any, every Interactive Data File required to be
submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this
chapter) during the preceding 12 months (or for such shorter period that the
registrant was required to submit and post such files). Yes o No o





Indicate
by check mark whether the registrant is a large accelerated filer, an
accelerated filer, a non-accelerated filer, or a smaller reporting
company.  See the definitions of “large accelerated filer,”
“accelerated filer” and “smaller reporting company” in Rule 12b-2 of the
Exchange Act.





Large
      accelerated filer o
            Accelerated
      filer oNon-accelerated
      filer   o (Do not check if
      a smaller reporting company)
            Smaller
      reporting company x





Indicate
by check mark whether the registrant is a shell company (as defined in Rule
12b-2 of the Exchange Act).




Yes o No x




APPLICABLE
ONLY TO CORPORATE ISSUERS





Indicate
the number of shares outstanding of each of the issuer’s classes of common
stock, as of the latest practicable date: As of May 8, 2009, there were
17,461,099 shares of the issuer’s common stock issued and outstanding, which
included 16,780,199 shares outstanding and stock subscriptions payable for an
additional 680,900 shares.










CURATECH
INDUSTRIES, INC.


FORM
10-Q




TABLE
OF CONTENTS





PART
I – FINANCIAL INFORMATION


Page


Item
      1.
            Financial
      Statements (Unaudited)
            3Balance
      Sheets — As of March 31, 2009 (Unaudited)and
      December 31, 2008
            5Statements
      of Operations for the Three MonthsEnded
      March 31, 2009 and 2008 (Unaudited)
            6Statements
      of Cash Flows for the Three MonthsEnded
      March 31, 2009 and 2008 (Unaudited)
            7Notes
      to Financial Statements (Unaudited)
            8Item
      2.
            Management’s
      Discussion and Analysis of FinancialCondition
      and Results of Operation
            10Item
      3.
            Quantitative
      and Qualitative Disclosures AboutMarket
      Risk
            13Item
      4.
            Controls
      and Procedures
            14PART
      II – OTHER INFORMATIONItem
      1.
            Legal
      Proceedings
            14Item
      1A.
            Risk
      Factors
            14Item
      2.
            Unregistered
      Sales of Equity Securities and Use of Proceeds
            14Item
      3.
            Defaults
      Upon Senior Securities
            15Item
      4.
            Submission
      of Matters to a Vote of Security Holders
            15Item
      5.
            Other
      Information
            15Item
      6.
            Exhibits
            15




2




PART I -
FINANCIAL INFORMATION





Item
1.   Financial Statements.





The
balance sheets of CuraTech Industries, Inc., a Nevada corporation (“CuraTech” or
the “Company”) as of March 31, 2009 (unaudited) and December 31, 2008, the
related unaudited statements of operations for the three month periods ended
March 31, 2009 and March 31, 2008, the related unaudited statements of cash
flows for the three month periods ended March 31, 2009 and March 31, 2008, and
the notes to the unaudited financial statements follow.  The financial
statements have been prepared by CuraTech’s management in conformity with United
States generally accepted accounting principles.  In the opinion of
management, all adjustments considered necessary for a fair presentation of the
results of operations and financial position have been included and all such
adjustments are of a normal recurring nature.  Operating results for
the period ended March 31, 2009, are not necessarily indicative of the results
that can be expected for the year ending December 31, 2009.





The names
“CuraTech”, “we”, “our” and “us” used in this report refer to CuraTech
Industries, Inc.




3




CURATECH
INDUSTRIES, INC.




INDEX
TO FINANCIAL STATEMENTS








Balance
      Sheets – March 31, 2009 (Unaudited)and
      December 31, 2008
              5Statements
      of Operations (Unaudited) for the Three MonthsEnded
      March 31, 2009 and 2008
              6Statements
      of Cash Flows (Unaudited) for the Three MonthsEnded
      March 31, 2009 and 2008
              7Notes
      to Financial Statements
              8




4




CURATECH
INDUSTRIES, INC.
 Balance
Sheets
 
 ASSETSMarch
      31,
              
              December
      31,2009
              
              2008CURRENT
      ASSETS
              (Unaudited)Cash
              
              $
              55,842
              
              
              $
              8,305Note
      receivable
              
              
              200,000
              
              
              
              -Interest
      receivable
              
              
              1,979
              
              
              
              -Total
      Current Assets
              
              
              257,821
              
              
              
              8,305FIXED
      ASSETS, Net
              
              
              3,747
              
              
              
              4,087OTHER
      ASSETSReal
      estate investment
              
              
              230,862
              
              
              
              230,862Total
      Other Assets
              
              
              230,862
              
              
              
              230,862TOTAL
      ASSETS
              
              $
              492,430
              
              
              $
              243,254LIABILITIES AND
      STOCKHOLDERS' EQUITY (DEFICIT)CURRENT
      LIABILITIESAccounts
      payable
              
              $
              14,927
              
              
              $
              13,467Accrued
      officer salaries
              
              
              102,077
              
              
              
              66,434Notes
      payable - related party
              
              
              191,500
              
              
              
              -Notes
      payable
              
              
              60,000
              
              
              
              -Accrued
      interest payable - related party
              
              
              1,213
              
              
              
              -Accrued
      interest payable
              
              
              800
              
              
              
              -Total
      Current Liabilities
              
              
              370,517
              
              
              
              79,901TOTAL
      LIABILITIES
              
              
              370,517
              
              
              
              79,901STOCKHOLDERS'
      EQUITY (DEFICIT)Common
      stock: 25,000,000 shares authorized;$0.001
      par value; 16,780,199 shares issuedand
      outstanding
              
              
              16,780
              
              
              
              16,780Additional
      paid-in capital
              
              
              4,337,013
              
              
              
              4,337,013Stock
      subscriptions receivable
              
              
              (99,252
              )
              
              
              (99,252
              )Stock
      subscriptions payable
              
              
              680,900
              
              
              
              580,900Accumulated
      deficit
              
              
              (4,813,528
              )
              
              
              (4,672,088
              )Total
      Stockholders' Equity (Deficit)
              
              
              121,913
              
              
              
              163,353TOTAL
      LIABILITIES AND STOCKHOLDERS'EQUITY
      (DEFICIT)
              
              $
              492,430
              
              
              $
              243,254
 
 The
accompanying notes are an integral part of these financial
statements.
  5


CURATECH
INDUSTRIES, INC.
 Statements
of Operations
 (Unaudited)
 
 From
      InceptionFor
      the Three
              
              
              on
      April 25,Months
      Ended
              
              
              2006
      ThroughMarch
      31,
              
              
              March
      31,2009
              
              
              2008
              
              
              2009REVENUES
              
              $
              -
              
              
              $
              -
              
              
              $
              -OPERATING
      EXPENSESGeneral
      and administrative
              
              
              42,047
              
              
              
              106,207
              
              
              
              2,012,506Consulting
              
              
              36,518
              
              
              
              850
              
              
              
              2,016,803Officer
      compensation
              
              
              62,500
              
              
              
              0
              
              
              
              312,500Depreciation
              
              
              341
              
              
              
              341
              
              
              
              3,065Total
      Operating Expenses
              
              
              141,406
              
              
              
              107,398
              
              
              
              4,344,874LOSS
      FROM OPERATIONS
              
              
              (141,406
              )
              
              
              (107,398
              )
              
              
              (4,344,874
              )OTHER
      EXPENSESImpairment
      of assets
              
              
              -
              
              
              
              -
              
              
              
              (472,500
              )Interest
      expense
              
              
              (2,013
              )
              
              
              -
              
              
              
              (2,013
              )Interest
      income
              
              
              1,979
              
              
              
              1,480
              
              
              
              5,859Total
      Other Expenses
              
              
              (34
              )
              
              
              1,480
              
              
              
              (468,654
              )NET
      LOSS
              
              $
              (141,440
              )
              
              $
              (105,918
              )
              
              $
              (4,813,528
              )BASIC
      LOSS PER SHARE
              
              $
              (0.01
              )
              
              $
              (0.01
              )WEIGHTED
      AVERAGE NUMBEROF
      SHARES OUTSTANDING
              
              
              16,780,199
              
              
              
              18,580,199
 The
accompanying notes are an integral part of these financial
statements.
  6




CURATECH
INDUSTRIES, INC.
 Statements
of Cash Flows
 (Unaudited)
 
 From
      Inceptionon
      April 25,For
      the Three Months Ended
              
              
              2006
      ThroughMarch
      31,
              
              
              March
      31,2009
              
              
              2008
              
              
              2009CASH
      FLOWS FROM OPERATING ACTIVITIESNet
      loss
              
              $
              (141,440
              )
              
              $
              (105,918
              )
              
              $
              (4,813,528
              )Adjustments
      to reconcile net loss tonet
      cash used by operating activities:Depreciation
              
              
              340
              
              
              
              340
              
              
              
              3,064Common
      stock issued for services
              
              
              -
              
              
              
              -
              
              
              
              3,153,000Impairment
      of assets
              
              
              -
              
              
              
              -
              
              
              
              472,500Services
      contributed by officers
              
              
              -
              
              
              
              -
              
              
              
              7,000Changes
      in operating assets and liabilitiesIncrease
      in receivable - related party
              
              
              (1,979
              )
              
              
              (1,480
              )
              
              
              (51,979
              )Increase
      in accrued expenses - related parties
              
              
              36,856
              
              
              
              0
              
              
              
              36,856Increase
      in accounts payable and accrued expenses
              
              
              2,260
              
              
              
              2,450
              
              
              
              76,873Net
      Cash Used by Operating Activities
              
              
              (103,963
              )
              
              
              (104,608
              )
              
              
              (1,116,214
              )CASH
      FLOWS FROM INVESTING ACTIVITIESPurchase
      of investment
              
              
              -
              
              
              
              -
              
              
              
              (150,000
              )Cash
      paid for real estate
              
              
              -
              
              
              
              (230,862
              )
              
              
              (230,862
              )Net
      Cash Used by Investing Activities
              
              
              -
              
              
              
              (230,862
              )
              
              
              (380,862
              )CASH
      FLOWS FROM FINIANCING ACTIVITIESCommon
      stock issued for cash
              
              
              -
              
              
              
              -
              
              
              
              603,559Cash
      received in acquisition
              
              
              -
              
              
              
              -
              
              
              
              137,673Cash
      received on note payable
              
              
              60,000
              
              
              
              -
              
              
              
              65,288Cash
      received on note payable - related
              
              
              191,500
              
              
              
              -
              
              
              
              191,500Cash
      paid on notes receivable
              
              
              (200,000
              )
              
              
              -
              
              
              
              (200,000
              )Cash
      received on subscriptions receivable
              
              
              -
              
              
              
              -
              
              
              
              73,998Cash
      received on subscriptions payable
              
              
              100,000
              
              
              
              450,900
              
              
              
              680,900Net
      Cash Provided by Financing Activities
              
              
              151,500
              
              
              
              450,900
              
              
              
              1,552,918NET
      DECREASE IN CASH
              
              
              47,537
              
              
              
              115,430
              
              
              
              55,842CASH
      AT BEGINNING OF PERIOD
              
              
              8,305
              
              
              
              58,160
              
              
              
              -CASH
      AT END OF PERIOD
              
              $
              55,842
              
              
              $
              173,590
              
              
              $
              55,842SUPPLIMENTAL
      DISCLOSURES OFCASH
      FLOW INFORMATIONCASH
      PAID FOR:Interest
              
              $
              -
              
              
              $
              -
              
              
              $
              -Income
      Taxes
              
              $
              -
              
              
              $
              -
              
              
              $
              -NON-CASH
      FINANCING ACTIVITIESCommon
      stock issued for services
              
              $
              -
              
              
              $
              -
              
              
              $
              3,153,000Services
      contributed by director
              
              $
              -
              
              
              $
              -
              
              
              $
              7,000
 
 The
accompanying notes are an integral part of these financial
statements.


7




CURATECH
INDUSTRIES, INC.
 Notes to
the Financial Statements (Continued)
 March 31,
2009 and December 31, 2008




NOTE
      1 -
                BASIS
      OF FINANCIAL STATEMENT PRESENTATION
 
 The
accompanying unaudited condensed financial statements have been prepared by the
Company pursuant to the rules and regulations of the Securities and Exchange
Commission. Certain information and footnote disclosures normally included in
financial statements prepared in accordance with accounting principles generally
accepted in the United States of America have been condensed or omitted in
accordance with such rules and regulations.  The information furnished
in the interim condensed financial statements includes normal recurring
adjustments and reflects all adjustments, which, in the opinion of management,
are necessary for a fair presentation of such financial
statements.  Although management believes the disclosures and
information presented are adequate to make the information not misleading, it is
suggested that these interim condensed financial statements be read in
conjunction with the Company's most recent audited financial statements and
notes thereto  included in its December 31, 2008 Annual Report on Form
10-KSB of the Company.  Operating results for the three months ended
March 31, 2009 are not necessarily indicative of the results that may be
expected for the year ending December 31, 2009.
 
 NOTE
      2 -
                GOING
      CONCERN
 
 The
Company's financial statements are prepared using accounting principles
generally accepted in the United States of America applicable to a going concern
which contemplates the realization of assets and liquidation of liabilities in
the normal course of business.  The Company has not established
revenues sufficient to cover its operating costs and allow it to continue as a
going concern.   Management intends to increase operations
through expanding its operations into other locals, in the interim, management
and primary shareholders are committed to meeting the Company minimal operating
expenses.
 
 NOTE
      3 -
                AGREEMENT
      AND PLAN OF MERGER
 
 On
October 26, 2006, the Company completed the acquisition of MedaCure
International, Inc., a Nevada corporation located in Salt Lake City, Utah
(“MedaCure”). The acquisition was consummated pursuant to an agreement entered
into on June 22, 2006, whereby the Company agreed to merge its newly created,
wholly-owned subsidiary, CuraTech Acquisitions, Inc., with and into MedaCure
with MedaCure being the surviving entity as the Company’s wholly owned
subsidiary.
 
 Prior to
completion of the acquisition the Company changed its corporate name to CuraTech
Industries, Inc. The Company also changed its corporate domicile from the State
of Utah to Nevada.  Also, the Company added three new directors, each
nominated by MedaCure, to its Board of Directors.
 
 From the
consummation of the Merger Agreement, the Company has begun the development and
bringing to market a certain health supplement that is intended to enhance and
build-up the body’s natural immune system defenses. The Company intends to
commence commercial marketing of its supplement in the near future primarily
outside the U.S. Initial marketing in the U.S. will primarily be to the
veterinarian market for use in treating animals. The Company also intends to
initiate a collaboration and partnering program that will focus on developing
business alliances designed to generate sales, applications and marketing
opportunities.
  NOTE
      4 -
                SIGNIFICANT
      EVENTS
 
 Equity Activity –
During the three months ended March 31, 2009 the Company received $100,000 from
various investors in exchange for 100,000 shares of common stock at $1.00 per
share.  As of March 31, 2009 the shares have not been issued;
therefore, this amount has been recorded as stock subscriptions payable in the
Company’s financial statements.
  8
  CURATECH
INDUSTRIES, INC.
 Notes to
the Financial Statements (Continued)
 March 31,
2009 and December 31, 2008
  NOTE
      4 -
                SIGNIFICANT
      EVENTS (Continued)
 
 Notes Payable – Related
Party – During the three months ended March 31, 2009, the Company
received a total of $221,500 in cash from related parties.  These
amounts have been recorded as notes payable – related parties.  Each
note is unsecured, bears interest at a rate of 8.0% per annum, and is due on
demand.  As of March 31, 2009 the Company had made payments on these
notes amounting to $30,000.  Accrued interest payable on these notes
totaled $2,013 as of March 31, 2009.
 
 Notes Receivable –
During the three months ended March 31, 2009, the Company loaned a total of
$200,000 to various unrelated entities.  These amounts have been
recorded as notes receivable in these financial statements.  The notes
are unsecured, bear interest at a rate of 9.5% per annum, and are due on
demand.  The Company recorded $1,979 in interest income on these notes
during the three months ended March 31, 2009.
  9
  Item
2.   Management’s Discussion and Analysis of Financial Condition
and Results of Operations.
 
 The
following information should be read in conjunction with the financial
statements and notes thereto appearing elsewhere in this Form 10-Q.
 
 Recent
Events
 
 During
the quarter ended March 31, 2009, the Company received $100,000 in gross
offering proceeds for which the Company has agreed to issue 100,000 shares at
$1.00 per share.  The shares have not been issued yet.  The
Company anticipates issuing the shares in the second quarter ending June 30,
2009.
 
 Plan
of Operation
 
 Following
the completion of the acquisition of MedaCure on October 26, 2006, we have
become engaged in the developing and marketing of MedaCure’s health supplement
that is believed to enhance and build-up the body’s natural immune system
defenses in both humans and animals.  In November 2008, we engaged a
third party manufacturer to begin manufacturing the MedaCure
product.  A total of 785,000 capsules have been manufactured to date.
Our next priority will be to establish new facilities for our corporate
headquarters and to warehouse the product. Management is seeking a 3,000 square
foot facility that can be leased on a long-term basis. The facility will also
handle shipping of product. We have not selected a final site, but we are
searching for one in Utah County, Utah.
 
 Contemporaneous
with selecting the site for our headquarters and warehouse, we will be creating
a distribution network that will focus on initiating a collaboration and
partnering program and developing business alliances designed to generate sales,
applications and marketing opportunities. At present, we are negotiating with
two groups of potential distributors.  We anticipate that during the
next 12 months we will hire approximately 10-15 persons, 3-5 for administrative
duties, sand 7-10 for sales and marketing.
 
 We
estimate that during the next 12 months we will need approximately $500,000 to
establish our headquarters/warehouse facility, establish a sales and
distribution network, and begin selling activities.  We anticipate
that the source of the remaining funds needed will be from the private sale of
securities and/or other financing activities conducted by our officers and
directors.  We hope to raise approximately $500,000 during 2009,
although there presently are no commitments for funds, and we cannot offer any
assurance that we will be able to raise such funds on terms acceptable to the
Company.
 
 Inflation
 
 In the
opinion of management, inflation has not and will not have a material effect on
our operations in the immediate future. Management will continue to monitor
inflation and evaluate the possible future effects of inflation on our business
and operations.
  10
 
 Results of Operations -Three
Months Ended March 31, 2009 compared to the Three Months Ended March 31,
2008.
 
 Revenues
 
 Revenues from continuing operations for
the three month period ended March 31, 2009 were $-0-
compared to $-0- for the three month period ended March 31,
2008.  This lack of revenues was due primarily to the fact that we
have not yet commenced sales of our MedaCure product.  We anticipate
such sales may begin as early as second quarter 2009.
 
 Expenses
 
 Total operating expenses for the three
month period ended March 31, 2009 were $141,406, an increase of $34,008 from the
$107,398 of total operating expenses incurred in the three month period ended
March 31, 2008.  General and administrative expenses for the three
month period ended March 31, 2009 were $42,047, a decrease of $64,160 from the
$106,207 of general and administration expenses incurred during the three months
ended March 31, 2008. Consulting expenses totaled $36,518 in the three months
ended March 31, 2009, an increase of $35,668 from the $850 of consulting
expenses incurred in the three months ended March 31, 2008.  Officer
compensation totaled $62,500 in the three months ended March 31, 2009 compared
to $-0- in the three months ended March 31, 2008.  The Company
anticipates that general and administrative expenses and consulting expenses
will increase in the future as the Company’s sales activities
commence.  The Company anticipates that officer compensation should
remain at the current level for the rest of 2009.
 
 Net
Loss
 
 We reported a net loss of $141,440, or
$0.01 per share for the three months ended March 31, 2009, which is $35,522 more
than the $105,918 net loss, or $0.01 per share, incurred during the three months
ended March 31, 2008.  The increased net loss is primarily attributed
to the significant increase in consulting expense and officer compensation
during the later period partially offset by a substantial reduction in general
and administrative expenses incurred during the quarter ended March 31,
2009.
 
 Liquidity
and Capital Resources
 
 At March
31, 2009, our current assets consisted of cash on hand of $55,842, a note
receivable of $200,000 and interest receivable of $1,979.  We believe
that current cash on hand is not sufficient to satisfy our cash requirements for
the next twelve months, which we estimate to be approximately
$500,000.  Due to the fact that our limited operations have not
generated cash flow sufficient to cover ongoing business expenses, we may have
to rely on our directors, or on outside sources, to provide additional
funds.  However, we have no agreements with anyone to provide future
funds to our Company. If our directors are unable to provide future funding, if
the need arises, we may have to look at alternative sources of funding. There is
no assurance that such funds will be available or, that even if they are
available, that they will be available on terms that will be acceptable to us.
In the event we are unable to secure necessary future funding, we may have to
curtail our business or cease operations completely.  At the present
time, the Company is attempting to raise additional funds through a private
placement offering of the Company’s common stock.  No one is obligated
to purchase any additional shares in the offering.
 
 At March 31, 2009, we had total assets
of $492,430 and stockholders' equity of $121,913, compared to total assets of
$243,254 and total stockholders' equity of $163,353 at December 31,
2008.
  11
 
 All of the Company’s liabilities of
$370,517 as of March 31, 2009 are current liabilities due within the next year,
and primarily consist of $191,500 in notes payable related party, $102,077
accrued officer salaries and $60,000 in notes payable.
 
 The Company expects to hire 10-15
employees in the next 12 months.
 
 Capital
Expenditures
 
 The Company expended no amounts on
capital expenditures during the three months ended March 31,
2009.  The Company has no current plans for capital
expenditures.
 
 Critical
Accounting Policies
 
 In the notes to the audited
consolidated financial statements for the year ended December 31, 2008, included
in the Company’s Annual Report on Form 10-K, the Company discusses those
accounting policies that are considered to be significant in determining the
results of operations and its financial position. The Company believes that the
accounting principles utilized by it conform to accounting principles generally
accepted in the United States of America.
 
 The preparation of financial statements
requires Company management to make significant estimates and judgments that
affect the reported amounts of assets, liabilities, revenues and expenses. By
their nature, these judgments are subject to an inherent degree of uncertainty.
On an on-going basis, the Company evaluates estimates. The Company bases its
estimates on historical experience and other facts and circumstances that are
believed to be reasonable, and the results form the basis for making judgments
about the carrying value of assets and liabilities.  The actual
results may differ from these estimates under different assumptions or
conditions.
 
 Going
Concern
 
 The Company’s auditors expressed
substantial doubt as to the Company’s ability to continue as a going concern as
a result of recurring losses, lack of revenue-generating activities and a
deficit accumulated during the development stage in the amount of
$4,813,528as of March
31, 2009. The Company’s ability to continue as a going concern is subject to the
ability of the Company to realize a profit from operations and /or obtain
funding from outside sources.  Since the Company has no revenue
generating operations, our plan to address the Company’s ability to continue as
a going concern over the next twelve months includes obtaining additional
funding from the sale of our securities.  Although we believe that we
will be able to obtain the necessary funding to allow the Company to remain a
going concern through the methods discussed above, there can be no assurances
that such methods will prove successful.
 
 Net
Operating Loss
 
 We have accumulated approximately
$1,030,046 of net operating loss carryforwards as of March 31, 2009, which may
be offset against taxable income and income taxes in future years. The use of
these losses to reduce future income taxes will depend on the generation of
sufficient taxable income prior to the expiration of the net operating loss
carryforwards.  The carry-forwards expire in the year 2029. In the
event of certain changes in control, there will be an annual limitation on the
amount of net operating loss carryforwards which can be used. No tax benefit has
been reported in the financial statements for the year ended December 31, 2008
because there is a 50% or greater chance that the carryforward will not be used.
Accordingly, the potential tax benefit of the loss carryforward is offset by a
valuation allowance of the same amount.
  12
 
 Forward
Looking and Cautionary Statements
 
 This report, including the sections
entitled "Business," "Risk Factors" and "Management's Discussion and Analysis or
Plan of Operations" contains forward-looking statements. These statements relate
to future events or our future financial performance and involve known and
unknown risks and uncertainties. These factors may cause our company's or our
industry's actual results, levels of activity, performance or achievements to be
materially different from those expressed or implied by the forward- looking
statements. These risks and other factors include those listed under "Risk
Factors" and elsewhere in this report. In some cases, you can identify
forward-looking statements by terminology such as "may," "will" "should,"
"expects," "intends," "plans,"
anticipates,"  "believes,"  "estimates,"  "predicts,"
"potential," "continue," or the negative of these terms or other comparable
terminology.
 
 You should be aware that a variety of
factors could cause actual results to differ materially from the anticipated
results or other matters expressed in forward-looking
statements.  These risks and uncertainties, many of which are beyond
our control, include:
  *
                the
      sufficiency of existing capital resources and our ability to raise
      additional capital to fund cash requirements for future
      operations;
  *
                uncertainties
      following any successful acquisition or merger related to the future rate
      of growth of our business and acceptance of our products and/or
      services;
  *
                volatility
      of the stock market, particularly within the technology sector;
      and
  *
                general
      economic conditions.
 
 Although we believe the expectations
reflected in these forward-looking statements are reasonable, such expectations
cannot guarantee future results, levels of activity, performance or
achievements.
 
 You are cautioned that any
forward-looking statements are not guarantees of future performance and are
subject to risks and uncertainties.  Actual results may differ
materially from those included within the forward-looking statements as a result
of various factors.  Cautionary statements in the risk factors section
and elsewhere in this report identify important risks and uncertainties
affecting our future, which could cause actual results to differ materially from
the forward-looking statements made in this report.
 
 Item
3.   Quantitative and Qualitative Disclosures About Market
Risk.
 
 A
“smaller reporting company” (as defined by Item 10 of Regulation S-K) is not
required to provide the information required by this Item.
  13
 
 Item
4.   Controls and Procedures.
 
 Under the
supervision and with the participation of management, our principal executive
officer and principal financial officer evaluated the effectiveness of the
design and operation of our disclosure controls and procedures, as defined in
Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934
(“Exchange Act”), as of March 31, 2009.  Based on this evaluation, our
principal executive officer and our principal financial officer concluded that,
as of the end of the period covered by this report, our disclosure controls and
procedures were effective and adequately designed to ensure that the information
required to be disclosed by us in the reports we submit under the Exchange Act
is recorded, processed, summarized and reported within the time periods
specified in the applicable rules and forms and that such information was
accumulated and communicated to our chief executive officer and chief financial
officer, in a manner that allowed for timely decisions regarding required
disclosure.
 
 During
the last fiscal quarter ended March 31, 2009, there has been no change in
internal control over financial reporting that has materially affected, or is
reasonably likely to materially affect our internal control over financial
reporting.
 
 ANY
FORWARD-LOOKING STATEMENTS INCLUDED IN THIS FORM 10-Q REPORT REFLECT
MANAGEMENT’S BEST JUDGMENT BASED ON FACTORS CURRENTLY KNOWN AND INVOLVE RISKS
AND UNCERTAINTIES.  ACTUAL RESULTS MAY VARY MATERIALLY.
 
 PART II -
OTHER INFORMATION
 
 Item
1.   Legal Proceedings.
 
 There are
no material pending legal proceedings to which we or our subsidiary is a party
or to which any of our property is subject and, to the best of our knowledge, no
such action against us is contemplated or threatened.
 
 Item
1A.   Risk Factors.
 
 A
“smaller reporting company” (as defined by Item 10 of Regulation S-K) is not
required to provide the information required by this Item.
 
 Item
2.   Unregistered Sales of Equity Securities and Use of
Proceeds.
 
 During
the three month period ended March 31, 2009, the Company has not sold any shares
of its common stock without registration under the Securities Act of 1933,
except for the following:
 
 (1) The
Company received a total of $100,000 in gross offering proceeds from
subscriptions receivable from one person during the quarter ended March 31,
2009.  The Company plans to issue 100,000 shares of its common stock
at $1.00 per share to the subscriber.  The shares will be issued
without registration pursuant to Section 4(2) of the Securities Act of 1933
and/or Rule 506 of Regulation D for transactions not involving any public
offering.  The purchaser represented that he is acquiring the shares
with investment intent, and the certificate representing the shares will be
given a restricted legend.  The purchaser received a private placement
memorandum prior to making his/her investment.
  14
  For a
description of any sales of shares of the Company’s unregistered stock made in
the past three years, please refer to the Company’s Annual Reports on Form
10-KSB or Form 10-K, and the Company’s Quarterly Reports on Form 10-QSB or Form
10-Q filed since December 31, 2005.
 
 Item
3.   Defaults Upon Senior Securities.
  None; not
applicable.
 
 Item
4.   Submission of Matters to a Vote of Security
Holders.
  None; not
applicable.
 
 Item
5.   Other Information.
  None; not
applicable.
 
 Item
6.   Exhibits.
  (a)
Exhibits.
  Exhibit
                  Number
                Description31.1
                Certification
      of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley
      Act of 2002
 
 31.2
                Certification
      of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley
      Act of 2002
 
 32.1
                Certification
      of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley
      Act of 2002
 
 32.2
                Certification
      of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley
      Act of 2002
  15
  SIGNATURES
 
 Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
  CURATECH INDUSTRIES,
      INC.Date:
      May 15, 2009
                  By:
                  /s/ Lincoln M. DastrupLincoln
      M. DastrupPresident,
      Chief Executive Officer, Chief Financial Officer and Chief Accounting
      Officer
  16